Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Consumers staying true to organics

This article was originally published in The Rose Sheet

Executive Summary

Consumers are not abandoning the organic lifestyle in the depressed economy, according to a new study from market researcher Mintel. According to the firm, nearly 40% of consumers say they have not changed their organic purchasing habits, and only 3% have stopped buying organic altogether. Some heavy users of natural and organic products have traded down to cheaper options, Mintel senior analyst David Browne notes, but "less frequent consumers of organic products have shown that they haven't shifted their behavior. This is good news," he says, because the group may begin buying more organic items once the economy is up and running (see 1Mintel Watching For Mood-Enhancing Beauty, Nature/Science Fusions In 2010 ).

You may also be interested in...



Mintel Watching For Mood-Enhancing Beauty, Nature/Science Fusions In 2010

Impacted by the economic recession, consumers are looking for personal-care products that offer protection and maybe even lift their spirits, Mintel suggests in its predictions for 2010

‘FDA Is Not the Villain:’ Study Highlights Need For Post-Market Focus To Spur Antibiotics

A study of drug approvals over more than three decades shows antimicrobials, including antibacterials, had consistently shorter development and review times than other types of products. While antibacterials were less likely to participate in special US FDA programs designed to help along review, experts said reimbursement reform, not new regulatory flexibility, is needed to help address the crisis of drug-resistant infections. 

Hahn: Expect More Telemedicine Promos, Public Service Messages On COVID-19 Protection From FDA

US FDA commissioner Stephen Hahn emphasized the important role that telemedicine, COVID-19 testing, and agency-reviewed face masks and ventilators have played during the pandemic in a 1 June speech.

UsernamePublicRestriction

Register

CO156977

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel